Form 3 - Initial statement of beneficial ownership of securities

                               POWER OF ATTORNEY

                  FOR SEC FILINGS ON FORMS ID, 3, 4, 5 AND 144

	The undersigned hereby constitutes and appoints each of Paul Little, Chief
Financial Officer, and Bryan Smith, General Counsel, Corporate Secretary, and
Chief Compliance Officer, of Eledon Pharmaceuticals, Inc., a Delaware
corporation (the "Company"), so long as each is employed at the Company, and
Shelly Heyduk, Chloe K. Keedy and Regina Braman, each of O'Melveny & Myers LLP
("OMM"), outside counsel to the Company, so long as each is employed at OMM, as
his true and lawful attorney-in-fact and agent (each, an "Attorney-In- Fact"),
with full power of substitution and resubstitution for him and in his name and
stead in any and all capacities, to sign and file for and on his behalf, in
respect of any acquisition, disposition or other change in ownership of any of
the securities of the undersigned, the following:

    (i) 	any Form ID to be filed with the Securities and Exchange Commission
            (the "SEC");

    (ii)	any Update Passphrase Request to be filed with the SEC;

    (iii)	any Initial Statement of Beneficial Ownership of Securities on Form
            3 to be filed with the SEC;

    (iv)	any Statement of Changes of Beneficial Ownership of Securities on
            Form 4 to be filed with the SEC;

    (v)	    any Annual Statement of Beneficial Ownership of Securities on Form 5
            to be filed with the SEC;

    (vi)	any Notice of Proposed Sale of Securities on Form 144 to be filed
            with the SEC; and

    (vii)	any and all agreements, certificates, receipts, or other documents
            in connection therewith.

      The undersigned hereby gives full power and authority to each Attorney-In-
Fact to seek and obtain as his representative and on his behalf, information on
transactions in the securities of the undersigned from any third party,
including brokers, employee benefit plan administrators and trustees, and the
undersigned hereby authorizes any such third party to release such information
to each Attorney-In-Fact and approves and ratifies any such release of
information.

      The undersigned hereby grants unto each Attorney-In-Fact full power and
authority to do and perform each and every act and thing requisite and necessary
in connection with such matters and hereby ratifies and confirms all that any
such Attorney-In-Fact or substitute may do or cause to be done by virtue hereof.

      The undersigned acknowledges that:

      (i)	neither the Company nor any Attorney-In-Fact assumes (i) any
            liability for the undersigned's responsibility to comply with the
            requirement of the Securities Exchange Act of 1934, as amended (the
            "Exchange Act"), (ii) any liability of the undersigned for any
            failure to comply with such requirements or (iii) any obligation or
            liability of the undersigned for profit disgorgement under Section
            16(b) of the Exchange Act; and

      (ii)	this Power of Attorney does not relieve the undersigned from
            responsibility for compliance with the undersigned's obligations
            under the Exchange Act, including without limitation the reporting
            requirements under Section 16 of the Exchange Act. This Power of
            Attorney shall remain in full force and effect with respect to the
            undersigned until revoked by the undersigned in a signed writing
            delivered to each Attorney-In- Fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 30 day of September, 2023.

               /s/ James Robinson
               _______________________
               James Robinson

Eledon Pharmaceuticals (NASDAQ:ELDN)
Historical Stock Chart
From Apr 2024 to May 2024